Cargando…
Self-Amplifying RNA Approach for Protein Replacement Therapy
Messenger RNA (mRNA) technology has already been successfully tested preclinically and there are ongoing clinical trials for protein replacement purposes; however, more effort has been put into the development of prevention strategies against infectious diseases. Apparently, mRNA vaccine approval ag...
Autores principales: | Papukashvili, Dimitri, Rcheulishvili, Nino, Liu, Cong, Ji, Yang, He, Yunjiao, Wang, Peng George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655356/ https://www.ncbi.nlm.nih.gov/pubmed/36361673 http://dx.doi.org/10.3390/ijms232112884 |
Ejemplares similares
-
Promising strategy for developing mRNA-based universal influenza virus vaccine for human population, poultry, and pigs– focus on the bigger picture
por: Rcheulishvili, Nino, et al.
Publicado: (2022) -
Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
por: Papukashvili, Dimitri, et al.
Publicado: (2021) -
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
por: Papukashvili, Dimitri, et al.
Publicado: (2022) -
Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses
por: Rcheulishvili, Nino, et al.
Publicado: (2023) -
Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
por: Liu, Cong, et al.
Publicado: (2022)